Analysis of Dynamic Surface Properties of Therapeutic Surfactants and Lung Phospholipids

Abstract

Exogenous surfactant is a specialized biomaterial used for substitution of the lipoprotein mixture normally present in lungs-pulmonary surfactant. Respiratory Distress Syndrome is a disease of preterm infants mainly caused by a deficiency of mature lung surfactant. Pulmonary surfactant is known to stabilize small alveoli and prevent them from collapsing during expiration due to its unique surface properties. A pulsating bubble surfactometer was used for in vitro analysis of surface parameters of therapeutic surfactants and of test formulations to be used for exogenous therapy in Respiratory Distress Syndrome. Surface parameters that were considered for comparison were minimum surface tension (γ_min) at three different frequencies (20,40 and 60 cpm), adsorption at two extreme bubble radii (R _min and R _max), stability index at the three frequencies, recruitment index and the surface viscoelastic parameters. Survanta, ALEC and Exosurf were compared with formulations consisting of the main phospholipids of pulmonary surfactant, namely dipalmitoyl phosphatidylcholine (PC), phosphatidylethanolamine (PE) and phosphatidylglycerol (PG) as well as binary mixtures of these phospholipids in the ratio 2:3. Survanta performed much better than the non-protein therapeutic surfactants in all parameters and at all three frequencies. Exosurf had a very low stability index and a very low modulus of surface dilatational elasticity at all three frequencies. The test compounds showed a frequency dependence in their performance. At 20 cpm, PC:PG (2:3) was the best test combination. It achieved a γ_min and stability index equivalent to Survanta at this frequency. None of the test compounds were comparable to Survanta at 40 and 60 cpm. These findings may have important therapeutic implications for exogenous surfactants.

Keywords

surfactant surface tension

Get full access to this article

View all access options for this article.

References

1. Reynolds, M. S. and K. Wallander . 1989. "Use of surfactant in the prevention and treatment of neonatal respiratory distress syndrome," Clin. Pharm., 8:559-576.

2. Martin, G. I. and B. D. Sindel . 1992. "Neonatal management of the very low birth weight infant: the use of surfactant," Clin. Perinatol., 19:461-468.

3. Vermont—Oxford Neonatal Network . 1996. "A multicenter randomized trial comparing synthetic surfactant with modified bovine surfactant extract in the treatment of neonatal respiratory distress syndrome," Pediatrics, 97:1-6.

4. Hafner, D. , R. Beume , U. Kilian , G. Krasznai and B. Lachmann . 1995. "Dose response comparisons of five lung surfactant factor (LSF) preparations in an animal model of adult respiratory distress syndrome (ARDS)," Br. J. Pharmacol., 115:451-458.

5. Corcoran, J. D. , P. Berggren , B. Sun , H. L. Halliday , B. Robertson and T. Curstedt . 1994. "Comparison of surface properties and physiological effects of a synthetic and a natural surfactant in preterm rabbits," Arch. Dis. Child., 71:F165-F169.

6. Cummings, J. J. , B. A. Holm , M. L. Huda , B. B. Hudak , W. H. Ferguson and E. A. Egan . 1992. "A controlled clinical comparison of four different surfactant preparations in surfactant deficient preterm lambs," Am. Rev. Respir. Dis., 145:999-1004.

7. Jobe, A. H. 1993. "Pulmonary surfactant therapy," N. Engl. J. Med., 328:861-867.

8. Amirkhanian, J. D. , R. Bruni , A. J. Waring , C. Navar , H. W. Tauesch . 1993. "Full length synthetic surfactant proteins, SP-B and SP-C, reduce surfactant inactivation by serum," Biochim. Biophys. Acta, 1169:315-320.

9. Hall, S. B. , A. R. Venkitaraman , J. A. Whitsett , B. A. Holm and R. H. Notter . 1992. "Importance of hydrophobic apoproteins as constituents of clinical exogenous surfactants," Am. Rev. Respir. Dis., 145:24-30.

10.

10. Yu, S. H. and F. Possmayer . 1993. "Adsorption, compression and stability of surface films from natural, lipid extract and reconstituted surfactants," Biochim. Biophys. Acta, 1167:264-271.

11.

11. Schubring, C. , C. J. Michel , W. Hobel and R. Goetz . 1976. "Oxygen consumption, heart rate, respiratory rate and rectal temperature in healthy newborns during the first two hours after birth," J. Perinat. Med., 4:72-77.

12.

12. Koyabashi, T. , A. Shido , K. Nitta , S. Inui , M. Ganzuka and B. Robertson . 1990. "The critical concentration of surfactant in fetal lung liquid at birth," Respir. Physiol., 80:181-192.

13.

13. Robertson, B. 1980. "Surfactant substitution: experimental models and clinical applications," Lung, 58:57-68.

14.

14. Yu, S. H. , P. G. R. Hatding and F. Possmayer . 1984. "Artificial pulmonary surfactant: Potential role for hexagonal H11 phase in the formation of a surface active monolayer," Biochim. Biophys. Acta, 776:37-47.

15.

15. Holm, B. A. , Z. Wang , E. A. Egan and R. H. Notter . 1996. "Content of dipalmitoyl phosphatidylcholine in lung surfactant: Ramifications for surface activity," Pediatr. Res., 39:805-811.

16.

16. Clements, J. A. 1982. "Lung surfactant compositions," United States Patent #4,312,860.

17.

17. Bangham, A. D. , N. G. A. Miller , R. J. Davies , L. A. Greendig and C. J. Morley . 1984. "Introductory remarks about artificial lung expanding compounds (ALEC)," Colloids Surfaces, 10:337-341.

18.

18. Yu, S. H. and F. Possmayer . 1994. "Effect of pulmonary surfactant protein A (SP-A) and calcium on the absorption of cholesterol and film stability," Biochim. Biophys. Acta, 1211:350-358.

19.

19. Enhorning, G. 1977. "Pulsating bubble technique for evaluating pulmonary surfactant," J. Appl. Physiol., 43:198-203.

20.

20. Scarpelli, E. M. , E. David , M. Cordova and A. J. Mautone . 1992. "Surface tension of therapeutic surfactants (Exosurf Neonatal, Infasurf and Survanta) as evaluated by standard methods and criteria," Am. J. Perinatol., 9:414-419.

21.

21. Clements, J. A. , R. F. Hustead , R. P. Johnson and I. Gribetz . 1961. "Pulmonary surface tension and alveolar stability," J. Appl. Physiol., 16:444-450.

22.

22. Notter, R. H. , R. Taubold and R. D. Mavies . 1982. "Hysteresis in saturated phospholipid films and its potential relevance for lung surfactant function in vivo," Exp. Lung Res., 3:109-127.

23.

23. Kitching, S. , G. D. W. Johnson , B. R. Midmore and T. M. Herrington . 1996. "Surface rheological data for a polymeric surfactant using a pulsed drop rheometer," J. Colloid Interface Sc., 177:58-69.

24.

24. Maylsa, K. , K. Lunkenheimer , R. Miller and C. Hartenstein . 1981. "Surface elasticity and frothability of n-octanol and n-octanoic acid solutions," Colloids Surfaces, 3:329-334.

25.

25. Bianco, H. and A. Marmur . 1993. "Gibbs elasticity of a soap bubble," J. Colloid Interface Sci., 158:295-302.

26.

26. Putz, G. , J. Goerke , H. W. Tauesch and J. A. Clements . 1994. "Comparison of captive and pulsating bubble surfactometers with use of lung surfactants," J. Appl. Physiol., 76:1425-1431.

27.

27. Hall, S. B. , M. S. Bermel , Y. T. Ko , H. J. Palmer , G. Enhorning and R. H. Notter . 1993. "Approximations in the measurement of surface tension on the oscillating bubble surfactometer," J. App. Physiol., 75:468-477.

28.

28. Petty, T. L. , O. K. Reiss , G. W. Paul , G. W. Silvers and N. D. Elkins . 1977. "Characteristics of pulmonary surfactant in adult respiratory distress syndrome associated with trauma and shock," Am. Rev. Respir. Dis., 115:531-536.

29.

29. Meban, C. 1980. "Surface elastic properties of surfactant from the lungs of neonatal pigs," Biol Neonate, 37:308-312.

30.

30. Dico, A. S. , S. Taneva , M. R. Morrow and K. M. W. Keough . 1997. "Effect of calcium on phospholipid interaction with pulmonary surfactant protein C," Biophys. J., 73:2595-2602.

31.

31. Pastrana, B. , A. J. Mautone and R. Mendelsohn . 1991. "Fourier transform infrared studies of secondary structure and orientation of pulmonary surfactant SP-C and its effect on the dynamic surface properties of phospholipids," Biochemistry, 30:10058-10064.

32.

32. Adamson, A. W. 1967. Physical chemistry of surfaces. New York: Interscience Publishers, 131-136.

33.

33. King, R. J. and J. A. Clements . 1972. "Surface active materials from dog lung. II Composition and physiological correlation," Am. J. Physiol., 223:715-733.

34.

34. Owen, M. J. , T. C. Kendrick , B. M. Kingston and N. C. Lloyd . 1967. "The surface chemistry of polyurethane foam formation. II The role of surface asticity," J. Colloid Interface Sc., 24:141-150.

35.

35. Owen, M. J. and T. C. Kendrick . 1968. "Surface chemistry of polyurethane foam formation. III Effect of gas diffusion between bubbles and surface viscosity on bubble stability," J. Colloid Interface Sc., 27:46-52.

36.

36. Taeusch, H. W. 1990. "Structure function relationships of bovine pulmonary surfactant proteins: SP-B and SP-C," Biochim. Biophys. Acta, 1044:43-49.

37.

37. Hallman, M. , G. Enhorning and F. Possmayer . 1985. "Composition and surface activity of normal and phosphatidyl glycerol deficient lung surfactant," Pediatr. Res., 19:286-292.

38.

38. Bangham, A. D. , C. J. Morley and M. C. Phillips . 1979. "The physical properties of an effective lung surfactant," Biochim. Biophys. Acta, 573:552-556.

39.

39. Mautone, A. J. , A. Ritter and J. Boyle . 1988. "A new method to evaluate expansion/compression stress-strain properties of surface films of biological surfactants," Colloids Surfaces., 300:223-241.